Accel-Heal Webinar, June 2020
Accel-Heal Commercial Director Paul McKenna introduces a webinar on wound healing. The Speakers are Dr Robin Martin BSC, PHD, Scientific Consultant and Liz Ovens, Independent Tissue Viability Specialist Nurse.
News
Accel-Heal – taking great pains to reduce wound pain
Wound pain can be excruciating, and this pain can have serious knock-on effects on the way in which a wound is treated. Although the gold standard treatment of venous leg ulcers (VLU) is the application of a full compression system, some patients can’t tolerate this treatment because of the pain caused by their wound. But...
Accel-Heal Made Easy Symposium
November 2019, Wounds UK, Harrogate, UK Two symposia at the Wounds UK conference in Harrogate in November 2019, outlined how Accel-Heal®, a single use, portable, easy-to-use electrical stimulation device can improve clinical practice. Dr Leanne Atkin opened the proceedings describing that the evidence is clear that compression therapy improves the healing of venous leg...
Establishment and inaugural meeting of the Clinical and Scientific Advisory Board
Accel-Heal are delighted to announce the establishment of a Clinical and Scientific Advisory Board comprised of eminent experts in the fields of Wound Healing research, science, clinical practice, pain management and health economics. The Board is chaired by Dr Robin Martin, PhD, Independent Scientific Consultant and is joined by the following members: Dr Leanne...
‘Electrical stimulation therapy and electroceutical treatment for the management of venous leg ulcers’ published in Community Wound Care
The use of innovative technologies for transforming and improving clinical outcomes and reducing costs in the NHS was an integral component of the NHS Five Year Forward View (2014). The use of electroceutical treatment has been demonstrated to both improve patient outcomes and reduce costs to the NHS for the management of chronic wounds. Read...
‘The health economic burden that acute and chronic wounds impose on an average clinical commissioning group / health board in the UK’ published in the Journal of Wound Care
It is estimated that the annual prevalence of chronic wounds is growing at the rate of 12%; largely as a result of an average healing rate of 43%. At this growth rate, chronic wounds alone (leg, foot and pressure ulcers) are expected to cost £5.3bn per annum by 2017/2018 and £9.4bn a year in another...
‘Health economic burden that different wound types impose on the UK’s National Health Service’ published in the International Wound Journal
Of the £5.3 billion the NHS spend every year treating wounds, over £3.0 billion a year is spent on managing chronic wounds (leg ulcers, diabetic foot ulcers and pressure sores) alone. The majority (74%) of this spend was on wounds that did not heal in the year. Healed wounds cost £800 million while unhealed wounds...
‘Using electroceutical treatment to reduce symptoms and improve healing in chronic wounds’ published in Primary Health Care
Use of electroceutical treatment effectively restores the current of injury, expediting normal healing and reducing chronic inflammation, biofilms, infection and associated symptoms, such as pain and high exudate. Clinical outcomes and QoL are improved and there are also economic benefits. Read the publication here: Using electroceutical treatment to reduce symptoms and improve healing in chronic...